Maintenance olaparib in patients aged ≥65 years with a germline BRCA mutation and metastatic pancreatic cancer: Phase III POLO trial Meeting Abstract


Authors: Kindler, H.; Hammel, P.; Reni, M.; Van Cutsem, E.; Macarulla, T.; Hall, M.; Park, J.; Hochhauser, D.; Arnold, D.; Oh, D.; Reinacher-Schick, A.; Tortora, G.; Algül, H.; O'Reilly, E.; McGuinness, D.; Cui, K.; Schlienger, K.; Locker, G.; Golan, T.
Abstract Title: Maintenance olaparib in patients aged ≥65 years with a germline BRCA mutation and metastatic pancreatic cancer: Phase III POLO trial
Meeting Title: ESMO 22nd World Congress on Gastrointestinal Cancer
Journal Title: Annals of Oncology
Volume: 31
Issue: Suppl. 3
Meeting Dates: 2020 Jul 1-4
Meeting Location: Virtual
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2020-07-01
Start Page: S218
Language: English
ACCESSION: WOS:000558722000392
DOI: 10.1016/j.annonc.2020.04.018
PROVIDER: wos
Notes: Meeting Abstract: SO-3 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Eileen O'Reilly
    780 O'Reilly